Adverum Biotechnologies
ADVM
ADVM
83 hedge funds and large institutions have $43.8M invested in Adverum Biotechnologies in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 24 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
30% less capital invested
Capital invested by funds: $62.3M → $43.8M (-$18.6M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $63K
Holders
83
Holding in Top 10
1
Calls
–
Puts
$63K
Top Buyers
| 1 | +$949K | |
| 2 | +$725K | |
| 3 | +$377K | |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$373K |
| 5 |
JPMorgan Chase & Co
New York
|
+$179K |
Top Sellers
| 1 | -$1.26M | |
| 2 | -$500K | |
| 3 | -$441K | |
| 4 |
RA
Royce & Associates
New York
|
-$380K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$346K |